Being efficiently presented by multiple HLA-DR alleles and by the psoriasis-associated MHC-I molecule HLA-Cw6*02 (1–3, 17), LL37 was found to be recognized by T cells in up to 40% of the patients with psoriasis. Here, CAMP is linked to psoriasis.